远程与居家医生访视在居家医院级照护中的比较:一项随机临床试验
该随机临床试验纳入172例需居家医院级照护的成人患者(感染、心力衰竭、慢性阻塞性肺疾病、哮喘),比较远程医生照护(首次居家访视后每日视频访视,由居家护士协助)与居家医生照护(每日居家医生访视)。主要终点不良事件经多因素泊松回归分析,远程组调整后平均每100例患者6.8起 vs 对照组3.9起,差值2.8(95%CI -3.3至8.9),支持非劣效性;患者体验问卷15评分差值-0.22(95%CI -1.00至0.56),支持非劣效性;30天再入院率绝对差值2.28%(95%CI -3.23%至7.79%),结论不确定。远程组19.0%患者需首次访视外的居家医生访视。作者认为该发现可能支持更高效、可扩展的居家医院模式,但需进一步研究。
要点
- 远程医生照护组调整后不良事件为每100例患者6.8起,居家医生照护组为3.9起,差值2.8(95%CI -3.3至8.9),支持非劣效性。
- 远程组与对照组患者体验问卷15评分调整后差值-0.22(95%CI -1.00至0.56),支持非劣效性。
- 30天再入院率调整后绝对差值2.28%(95%CI -3.23%至7.79%),结论不确定。
- 远程组中16例(19.0%)需要首次访视之外的居家医生访视。
- 研究因COVID-19提前终止入组,共随机172例(远程组84例,居家医生组88例)。
适用人群与场景
- 在学术医学中心和社区医院招募的172例成人患者,需要针对特定急性疾病(感染、心力衰竭、慢性阻塞性肺疾病、哮喘)的医院级照护,入组时间为2019年8月3日至2020年3月26日,随访于2020年4月26日结束。
诊断标准与关键阈值
- 主要终点非劣效性阈值设定为每100例患者10起不良事件。
处置流程与药物剂量
- 所有患者均接受居家急性照护,包括居家护士或急救员访视、静脉药物、远程监测和床旁检测。
- 远程照护组:首次居家医生访视后,由居家医院护士协助每日进行视频访视;如医生认为医学上必要,可在首次访视之外选择居家访视患者。
- 居家医生照护组(对照组):每日居家医生访视。
研究设计与关键结果
- 研究类型为随机临床试验,纳入172例成人患者(远程组84例,居家医生组88例),因COVID-19提前终止入组;平均(标准差)年龄69.3(18.0)岁,97例(56.4%)为女性,77例(45.0%)为白人,42例(24.4%)独居。
- 主要终点:远程组调整后平均每100例患者不良事件6.8起 vs 对照组3.9起,差值2.8(95%CI -3.3至8.9),支持非劣效性;不良事件包括跌倒、压力性损伤和谵妄。
- 次要终点:远程组 vs 对照组患者体验问卷15评分调整后平均差值-0.22(95%CI -1.00至0.56),支持非劣效性;30天再入院率调整后绝对差值2.28%(95%CI -3.23%至7.79%),结论不确定。
- 远程组中16例(19.0%)需要首次访视之外的居家医生访视。
证据类型、等级与局限
- 证据类型:随机临床试验;原文未报告证据等级。
- 局限:研究因COVID-19提前终止入组;作者指出需进一步研究。
对床旁实践的改变
- 作者认为,远程医生访视在居家医院照护中对于不良事件和患者体验非劣于居家医生访视,但居家医生照护对于支持许多接受远程照护的患者是必要的。
- 作者认为,该发现可能允许更高效、可扩展的居家医院模式,但需进一步研究。
指南或共识出处
- ClinicalTrials.gov标识符:NCT04080570。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Home hospital care is the substitutive provision of home-based acute care services usually associated with a traditional inpatient hospital. Many home hospital models require a physician to see patients at home daily, which may hinder scalability. Whether remote physician visits can safely substitute for most in-home visits is unknown.
OBJECTIVE: To compare remote and in-home physician care.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial assessed 172 adult patients at an academic medical center and community hospital who required hospital-level care for select acute conditions, including infection, heart failure, chronic obstructive pulmonary disease, and asthma, between August 3, 2019, and March 26, 2020; follow-up ended April 26, 2020.
INTERVENTIONS: All patients received acute care at home, including in-home nurse or paramedic visits, intravenous medications, remote monitoring, and point-of-care testing. Patients were randomized to receive physician care remotely (initial in-home visit followed by daily video visit facilitated by the home hospital nurse) vs in-home care (daily in-home physician visit). In the remote care group, the physician could choose to see the patient at home beyond the first visit if it was felt to be medically necessary.
MAIN OUTCOMES AND MEASURES: The primary outcome was the number of adverse events, compared using multivariable Poisson regression at a noninferiority threshold of 10 events per 100 patients. Adverse events included a fall, pressure injury, and delirium. Secondary outcomes included the Picker Patient Experience Questionnaire 15 score (scale of 0-15, with 0 indicating worst patient experience and 15 indicating best patient experience) and 30-day readmission rates.
RESULTS: A total of 172 patients (84 receiving remote care and 88 receiving in-home physician care [control group]) were randomized; enrollment was terminated early because of COVID-19. The mean (SD) age was 69.3 (18.0) years, 97 patients (56.4%) were female, 77 (45.0%) were White, and 42 (24.4%) lived alone. Mean adjusted adverse event count was 6.8 per 100 patients for remote care patients vs 3.9 per 100 patients for control patients, for a difference of 2.8 (95% CI, -3.3 to 8.9), supporting noninferiority. For remote care vs control patients, the mean adjusted Picker Patient Experience Questionnaire 15 score difference was -0.22 (95% CI, -1.00 to 0.56), supporting noninferiority. The mean adjusted 30-day readmission absolute rate difference was 2.28% (95% CI, -3.23% to 7.79%), which was inconclusive. Of patients in the remote group, 16 (19.0%) required in-home visits beyond the first visit.
CONCLUSIONS AND RELEVANCE: In this study, remote physician visits were noninferior to in-home physician visits during home hospital care for adverse events and patient experience, although in-home physician care was necessary to support many patients receiving remote care. Our findings may allow for a more efficient, scalable home hospital approach but require further research.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04080570.
参考来源
- Levine DM, Paz M, Burke K, et al. Remote vs In-home Physician Visits for Hospital-Level Care at Home: A Randomized Clinical Trial. JAMA Netw Open. 2022. PMID: 36040741. doi:10.1001/jamanetworkopen.2022.29067
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。